|
|
Article: Xhale Wins NIH / NIMH SBIR Phase II Grant for a Breath-Based Medication Adherence System
- Article from:
- Wireless News
- Article date:
- August 29, 2009
CopyrightProvided by ProQuest LLC. (Hide copyright information)
|
Wireless News
08-29-2009
Xhale Wins NIH / NIMH SBIR Phase II Grant for a Breath-Based Medication Adherence System
Type: News
Xhale, Inc. has been awarded a $1.7 million Small Business Innovation Research (SBIR) Phase II grant by the NIH National Institute of Mental Health (NIMH) to continue the development of SMART (Self Monitoring and Reporting Therapeutics), a breath-based medication adherence system for HIV/AIDS therapies.
In a release, the Company noted:
In 2007, NIH / NIMH awarded Xhale an SBIR Phase I grant to test the technical merit of SMART. SBIR Phase II grants enable SBIR Phase I grantees to further develop their technology and prepare it for commercialization. Xhale will use ...